The potential use of O6-Benzylguanine, and O6-Methylguanine for the treatment of Alzheimer's Disease, and T. brucei group trypanosomes infections
<p>Very recently we had published a paper entitled 'The Potential Development Sulfonylhydrazines for the Treatment of Alzheimer's Disease' [1]. Our paper was a development from an observation by others from 1997, where a remarkable remission in Dementia was observed in cancer pa...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
Annals of Systems Biology - Peertechz Publications,
2022-08-13.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | peertech__10_17352_asb_000018 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Philip G Penketh |e author |
| 700 | 1 | 0 | |a Raymond P Baumann |e author |
| 700 | 1 | 0 | |a Krishnamurthy Shyam |e author |
| 245 | 0 | 0 | |a The potential use of O6-Benzylguanine, and O6-Methylguanine for the treatment of Alzheimer's Disease, and T. brucei group trypanosomes infections |
| 260 | |b Annals of Systems Biology - Peertechz Publications, |c 2022-08-13. | ||
| 520 | |a <p>Very recently we had published a paper entitled 'The Potential Development Sulfonylhydrazines for the Treatment of Alzheimer's Disease' [1]. Our paper was a development from an observation by others from 1997, where a remarkable remission in Dementia was observed in cancer patients following treatment with the chemotherapeutic agent BCNU (Carmustine, 1,3-Bis(2-chloroethyl)-1-nitrosourea) [2]. </p><p><br></p> | ||
| 540 | |a Copyright © Philip G Penketh et al. | ||
| 546 | |a en | ||
| 655 | 7 | |a Opinion |2 local | |
| 856 | 4 | 1 | |u https://doi.org/10.17352/asb.000018 |z Connect to this object online. |